Animal African Trypanosomiasis in humans; an emerging zoonosis?
人类动物非洲锥虫病;
基本信息
- 批准号:347702735
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Grants
- 财政年份:2017
- 资助国家:德国
- 起止时间:2016-12-31 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Human African Trypanosomiasis (HAT) is known to be caused by two subspecies of trypanosomes: T. brucei gambiense and T. b. rhodesiense, which have acquired the ability to infect humans. Most other trypanosomes, which are responsible for animal trypanosomosis, such as T. b. brucei, T. congolense, and T. vivax, have been thought of as infective only to animals. We have found DNA traces of the animal pathogen T, congolense in humans loving in a remote area of Cameroon, suggesting that these may develp in a new human pathogen, a typical zoonosis. The overall aim of the project is to understand the processes leading to adaptation of animal pathogenic trypanosomes in humans.In accordance with this aim, the following four aspects will be addressed in the two years of the application period:Identification and characterisation of a potential zoonotic trypanosome The impact of the presence of zoonotic trypanosomes on human healthThe occurrence of potentially zoonotic trypanosomes in an active HAT location The occurrence of potentially zoonotic parasites in an area, where no recent HAT cases have been reported
已知非洲人类锥虫病是由两个亚种引起的:布氏冈比亚锥虫和布氏罗得西亚锥虫,这两个亚种已获得感染人类的能力。大多数其他导致动物锥虫病的锥虫,如布氏锥虫、刚果锥虫和间日锥虫,一直被认为只会感染动物。我们在喀麦隆一个偏远地区的人类身上发现了动物病原体刚果(金)的DNA痕迹,这表明它们可能在一种新的人类病原体中发展,一种典型的人畜共患病。该项目的总体目标是了解导致动物致病性锥虫在人类中的适应过程。根据这一目标,在两年的申请期内,将处理以下四个方面:潜在人畜共患病锥虫的鉴定和特征,人畜共患病锥虫存在对人类健康的影响,潜在人畜共患病锥虫在活跃的HAT地区的发生,潜在人畜共患病寄生虫在最近没有报告HAT病例的地区的发生
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professor Dr. Sörge Kelm其他文献
Professor Dr. Sörge Kelm的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Professor Dr. Sörge Kelm', 18)}}的其他基金
The Role of Trans-Sialidases from Trypanosoma Congolense in Nagana Disease
刚果锥虫转唾液酸酶在纳加纳病中的作用
- 批准号:
252602372 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Research Grants
The role of African trypanosomal trans-sialidases in the transmission of Trypanosoma congolense between the fly vector and life stock host suffering Nagana disease
非洲锥虫唾液酸转移酶在果蝇媒介和患有纳加那病的牲畜宿主之间传播刚果锥虫中的作用
- 批准号:
164877587 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Research Grants
Isolierung und Charakterisierung neuronaler Bindungspartner des Myelin-assoziierten Glykoproteins (MAG)
髓磷脂相关糖蛋白 (MAG) 神经元结合伴侣的分离和表征
- 批准号:
5386692 - 财政年份:1997
- 资助金额:
-- - 项目类别:
Research Grants
相似海外基金
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10511408 - 财政年份:2022
- 资助金额:
-- - 项目类别:
A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
调查马拉维野生动物中东非锥虫病生态学的“同一个健康”方法
- 批准号:
476178 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship Programs
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10677879 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10466942 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10296873 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10706306 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Reducing and replacing the animal cost of functional genetics in African trypanosomiasis
减少和替代非洲锥虫病功能遗传学的动物成本
- 批准号:
NC/W001144/1 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Research Grant
Development of new drug for African trypanosomiasis based on elucidation of the mechanism of antiprotozoal action by ribavirin.
基于利巴韦林抗原虫作用机制的阐明,开发治疗非洲锥虫病的新药。
- 批准号:
21K18230 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Development of a novel control measure for African trypanosomiasis based on the blocking of lifecycle progression
基于生命周期进展阻断的非洲锥虫病新型控制措施的开发
- 批准号:
20K07467 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Drug-diagnostic co-development in Tropical Medicine, combating Human African Trypanosomiasis
热带医学药物诊断联合开发,抗击非洲人类锥虫病
- 批准号:
18KK0454 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))